PropertyValue
?:abstract
  • Zoufaly A, Poglitsch M, Aberle JH, et al Human recombinant soluble ACE2 in severe COVID-19 Lancet Respir Med 2020;8: 1154–58—In this Case Report, “compassionate use” has been changed to “named patient use” and “good safety profile” has been changed to “acceptable safety profile” throughout the article These corrections have been made to the online version as of Oct 23, 2020, and the printed version is correct
?:creator
?:journal
  • The_Lancet_Respiratory_Medicine
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Correction to Lancet Respir Med 2020;8: 1154–58 (The Lancet Respiratory Medicine (2020) 8(11) (1154–1158), (S2213260020304185), (10.1016/S2213-2600(20)30418-5))
?:type
?:who_covidence_id
  • #899739
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/wlu12sq1>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/wlu12sq1>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all